Reich Kristian 4
4 · MoonLake Immunotherapeutics · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Reich Kristian
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-27+139,273→ 139,273 totalExercise: $41.77Exp: 2035-02-27→ Class A ordinary shares, par value $0.0001 per share (139,273 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 139,273 of the Issuer's Class A ordinary shares, vesting in four equal annual installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.